Scholarlink

<p>Breast cancer remains a major threat to women’s health and survival worldwide. Iroquois homeobox 1 (<i>IRX1</i>), a developmentally regulated transcription factor, acts as a tumor suppressor in several cancers. However, its mechanistic role in breast cancer remains elusive. In this study, we demonstrate that <i>IRX1</i> is downregulated in breast cancer tissues and cell lines due to promoter hypermethylation. <i>IRX1</i> functioned as a tumor suppressor both in vitro and in vivo. Mechanistically, IRX1 interacts with NME1 and promotes its nuclear localization. Subsequently, <i>NME1</i> facilitates the transcriptional regulation of <i>ACACA</i> by <i>IRX1</i>. The <i>IRX1</i>-<i>NME1</i> axis modulates de novo fatty acid synthesis and breast cancer progression by targeting <i>ACACA</i>. In conclusion, our findings reveal that the <i>IRX1- NME1</i>/<i>ACACA</i> axis plays a critical role in de novo fatty acid synthesis and breast cancer progression, providing new insights into gene regulatory interactions and highlighting its potential as a novel therapeutic target for breast cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

IRX1 suppresses breast cancer progression by inhibiting fatty acid de novo synthesis through downregulating ACACA expression

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月1日

查看全文
  • Wen-Bo Liu,
  • Lin-Yue Hai,
  • Yuan-Yuan Zhang,
  • Hao-Ran Yue,
  • Xiao-Feng Liu,
  • Bo-Wen Liu,
  • Xin Wang,
  • Xu-Chen Cao,
  • Yue Yu

摘要

Breast cancer remains a major threat to women’s health and survival worldwide. Iroquois homeobox 1 (IRX1), a developmentally regulated transcription factor, acts as a tumor suppressor in several cancers. However, its mechanistic role in breast cancer remains elusive. In this study, we demonstrate that IRX1 is downregulated in breast cancer tissues and cell lines due to promoter hypermethylation. IRX1 functioned as a tumor suppressor both in vitro and in vivo. Mechanistically, IRX1 interacts with NME1 and promotes its nuclear localization. Subsequently, NME1 facilitates the transcriptional regulation of ACACA by IRX1. The IRX1-NME1 axis modulates de novo fatty acid synthesis and breast cancer progression by targeting ACACA. In conclusion, our findings reveal that the IRX1- NME1/ACACA axis plays a critical role in de novo fatty acid synthesis and breast cancer progression, providing new insights into gene regulatory interactions and highlighting its potential as a novel therapeutic target for breast cancer.